Alteration in calcium channel properties is responsible for the neurotoxic action of a familial frontotemporal dementia tau mutation
Alteration in calcium channel properties is responsible for the neurotoxic action of a familial frontotemporal dementia tau mutation
复制标题
DOI:
10.1046/j.1471-4159.2003.02020.x
复制
发表时间:
2003-10-01
影响因子:
4.7
通讯作者:
Schellenberg, GD
中科院分区:
文献类型:
--
作者:
Furukawa, K;Wang, Y;Schellenberg, GD
Tau, a microtubule binding protein, is not only a major component of neurofibrillary tangles in Alzheimer's disease, but also a causative gene for hereditary frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). We show here that an FTDP-17 tau mutation (V337M) in SH-SY5Y cells reduces microtubule polymerization, increases voltage-dependent calcium current (I-Ca) density, and decreases I-Ca rundown. The reduced rundown of I-Ca by V337M was significantly inhibited by nifedipine (L-type Ca channel blocker), whereas omega-conotoxin GVIA (N-type Ca channel blocker) showed smaller effects, indicating that tau mutations affect L-type calcium channel activity. The depolarization-induced increase in intracellular calcium was also significantly augmented by the V337M tau mutation. Treatment with a microtubule polymerizing agent (taxol), an adenylyl cyclase inhibitor, or a protein kinase A (PKA) inhibitor, counteracted the effects of mutant tau on I-Ca. Taxol also attenuated the Ca2+ response to depolarization in cells expressing mutant tau. Apoptosis in SH-SY5Y cells induced by serum deprivation was exacerbated by the V337M mutation, and nifedipine, taxol, and a PKA inhibitor significantly protected cells against apoptosis. Our results indicate that a tau mutation which decreases its microtubule-binding ability augments calcium influx by depolymerizing microtubules and activating adenylyl cyclase and PKA.